Sodium Starch Glycolate Market Research Report 2026-2031: Total Revenue to Reach $125.30 Million by 2031 as Generic Drug Production Expands

Sodium Starch Glycolate Market Research Report 2026-2031: Total Revenue to Reach $125.30 Million by 2031 as Generic Drug Production Expands Dublin, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The "Sodium Starch Glycolate - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.

The global sodium starch glycolate market is projected to increase from USD 86.70 million in 2025 to USD 91.70 million in 2026. It is forecast to reach USD 125.30 million by 2031, registering a compound annual growth rate of 6.44% from 2026 to 2031. Market expansion is being supported by rising generic drug production, growing demand for nutraceutical tablets and capsules, and continued investment in pharmaceutical manufacturing.

The sodium starch glycolate market report provides value-based forecasts in USD million and segments the industry by source, application, and geography. Source categories include potato starch-based, corn starch-based, wheat starch-based, and other starch sources. Applications cover pharmaceuticals, food processing, personal care and cosmetics, and other end uses. The geographic analysis includes North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.

Generic Drug Production Strengthens Pharmaceutical Demand

Rising global production of generic medicines remains a major sodium starch glycolate market growth driver. The United States Food and Drug Administration approved 76 first-generic drugs in 2024, creating additional formulation demand for compendial excipients used in tablet manufacturing. Broad pharmacopeial alignment also enables suppliers to support pharmaceutical pipelines across the United States, Europe, and other regulated markets.

Prequalification programs are widening the addressable customer base as manufacturers serving public health procurement channels require excipients that comply with recognized quality standards. Sodium starch glycolate also benefits from established use in tablet formulations, as changing a qualified core excipient can add development costs, documentation requirements, and regulatory complexity.

Nutraceutical Tablets and Capsules Create New Opportunities

Expanding production of nutraceutical tablets and capsules is generating additional demand beyond prescription and generic pharmaceuticals. Tablet formats continue to attract manufacturers due to dosing accuracy, production scalability, and shelf-life performance. Greater attention to quality consistency, technical documentation, and product claims is also narrowing the specification gap between supplement-grade and pharmaceutical-grade ingredients.

Other factors influencing sodium starch glycolate market development include demand for plant-based excipients, innovation in novel drug delivery systems, and evolving regulatory requirements across pharmacopeial grades.

Starch Feedstock Volatility Remains a Market Restraint

Fluctuating starch feedstock costs present a significant challenge for manufacturers. Agricultural cycles, fertilizer prices, weather conditions, and energy expenses can affect both availability and production costs. Potato-based grades are particularly exposed to regional crop conditions because their feedstock supply is concentrated in Northern Europe.

Margin pressure may intensify when suppliers operate under fixed-price or slower-moving pharmaceutical contracts that limit the immediate transfer of higher input costs. Pricing power also differs between commodity products and higher-value pharmaceutical grades, creating uneven exposure across the competitive landscape.

Source Segment Analysis

Potato starch-based sodium starch glycolate accounted for 38.7% of global market share in 2025. Its leading position reflects established formulation preferences, chemical stability in moisture-sensitive products, pharmacopeial familiarity, and a long history of qualification in regulated tablet programs. European manufacturers also benefit from regional supply access and Drug Master File support.

Corn starch-based sodium starch glycolate is forecast to record the fastest source-segment growth, with a 6.32% CAGR from 2026 to 2031. Broad corn availability across North America and East Asia provides a diversified feedstock base, improves sourcing resilience, and supports more predictable year-round supply. These advantages are particularly relevant in markets seeking to reduce import dependence.

Regional Sodium Starch Glycolate Market Outlook

Asia-Pacific represented 34.8% of the sodium starch glycolate market in 2025, making it the largest regional market. India and China support high-volume excipient demand through their extensive tablet and capsule manufacturing industries. Export-focused Indian companies increasingly require harmonized grades and comprehensive documentation, while China's excipient Good Manufacturing Practice annex, effective January 1, 2026, is raising domestic compliance standards.

Regional technical investments are also helping pharmaceutical companies accelerate formulation development. DFE Pharma's Hyderabad center demonstrates the industry's increasing focus on providing technical support closer to major Asia-Pacific manufacturing clusters.

North America is forecast to register the fastest regional growth at a 5.8% CAGR through 2031. The outlook is supported by generic drug launches, a large nutraceutical industry, formulation upgrades, and growing interest in natural-origin excipient options. Dual-sourcing strategies and closer integration with Asia-Pacific manufacturing operations are also strengthening regional supply-chain resilience.

Europe remains a mature but strategically important market, supported by established excipient manufacturers and advanced formulation capabilities. Companies such as DFE Pharma and Roquette continue to influence international quality expectations. Roquette's expansion through the International Flavors and Fragrances Pharma Solutions transaction has also strengthened its position in oral dosage excipients and higher-value formulation support.

South America and the Middle East and Africa represent smaller shares of global revenue. However, investment in local pharmaceutical production and formulation capabilities is expected to create incremental sodium starch glycolate demand in both regions.

Key Topics Covered

1 Introduction

1.1 Study Assumptions and Market Definition

1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising global generic drug production

4.2.2 Growing nutraceutical tablet and capsule demand

4.2.3 Clean label and plant-based excipient preference

4.2.4 Innovation in Novel Drug Delivery Systems (NDDS)

4.2.5 Increasing use of convenience and instant food products

4.2.6 Price volatility of competing disintegrants is strengthening SSG's cost position

4.3 Market Restraints

4.3.1 Raw material price volatility in starch feedstocks

4.3.2 Regulatory burden across pharmacopeial grades

4.3.3 Moisture sensitivity and packaging complexity

4.3.4 Substitution pressure from crospovidone and croscarmellose sodium

4.4 Supply Chain Analysis

4.5 Regulatory Landscape

4.6 Technological Outlook

4.7 Porter's Five Forces

4.7.1 Threat of New Entrants

4.7.2 Bargaining Power of Suppliers

4.7.3 Bargaining Power of Buyers

4.7.4 Threat of Substitutes

4.7.5 Intensity of Competitive Rivalry

5 Market Size and Growth Forecasts (Value)

5.1 By Source

5.1.1 Potato Starch Based

5.1.2 Corn Starch Based

5.1.3 Wheat Starch Based

5.1.4 Other Starch Sources

5.2 By Application

5.2.1 Pharmaceuticals

5.2.2 Food Processing

5.2.3 Personal Care and Cosmetics

5.2.4 Other Applications

5.3 By Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 South America

5.3.5 Middle East and Africa

6 Competitive Landscape

6.1 Market Concentration

6.2 Strategic Moves

6.3 Market Positioning Analysis

6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)

6.4.1 DFE Pharma

6.4.2 Roquette Freres

6.4.3 JRS Pharma

6.4.4 Colorcon

6.4.5 Ashland

6.4.6 BASF SE

6.4.7 Merck KGaA

6.4.8 Shin-Etsu Chemical Co., Ltd.

6.4.9 Toshiba Chemical Corporation

6.4.10 Avantor, Inc.

6.4.11 Beneo GmbH

6.4.12 Meggle Pharma

6.4.13 Lubrizol Corporation

6.4.14 Nihon Shokuhin Kako Co., Ltd.

6.4.15 Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

6.4.16 Shreeji Pharma International

6.4.17 Liaocheng A Hua Pharmaceutical Co., Ltd.

6.4.18 Prachin Chemical

6.4.19 Muby Chemicals

6.4.20 Huzhou Zhanwang Pharmaceutical Co., Ltd.

7 Market Opportunities and Future Outlook

For more information about this report visit https://www.researchandmarkets.com/r/2u6cwt

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.